nodes	percent_of_prediction	percent_of_DWPC	metapath
Donepezil—CYP3A4—Temozolomide—malignant glioma	0.0986	1	CbGbCtD
Donepezil—HTR2A—choroid plexus—malignant glioma	0.034	0.15	CbGeAlD
Donepezil—HTR2A—cerebellar cortex—malignant glioma	0.0171	0.0758	CbGeAlD
Donepezil—Dysphasia—Temozolomide—malignant glioma	0.016	0.032	CcSEcCtD
Donepezil—HRH3—brainstem—malignant glioma	0.014	0.0617	CbGeAlD
Donepezil—HRH3—telencephalon—malignant glioma	0.0124	0.0547	CbGeAlD
Donepezil—HTR2A—pons—malignant glioma	0.0121	0.0536	CbGeAlD
Donepezil—HTR2A—vertebral column—malignant glioma	0.012	0.0532	CbGeAlD
Donepezil—Cerebral infarction—Carmustine—malignant glioma	0.0111	0.0222	CcSEcCtD
Donepezil—Retinal haemorrhage—Carmustine—malignant glioma	0.0111	0.0222	CcSEcCtD
Donepezil—Hemiplegia—Carmustine—malignant glioma	0.0101	0.0203	CcSEcCtD
Donepezil—HTR2A—telencephalic ventricle—malignant glioma	0.00997	0.0441	CbGeAlD
Donepezil—Hemiplegia—Temozolomide—malignant glioma	0.00979	0.0196	CcSEcCtD
Donepezil—HTR2A—pineal body—malignant glioma	0.00865	0.0382	CbGeAlD
Donepezil—Haemorrhage intracranial—Temozolomide—malignant glioma	0.00852	0.017	CcSEcCtD
Donepezil—Personality disorder—Carmustine—malignant glioma	0.00837	0.0167	CcSEcCtD
Donepezil—Grand mal convulsion—Carmustine—malignant glioma	0.0076	0.0152	CcSEcCtD
Donepezil—Cerebral ischaemia—Temozolomide—malignant glioma	0.00724	0.0145	CcSEcCtD
Donepezil—Faecal incontinence—Carmustine—malignant glioma	0.00717	0.0143	CcSEcCtD
Donepezil—HRH3—central nervous system—malignant glioma	0.00704	0.0311	CbGeAlD
Donepezil—Faecal incontinence—Temozolomide—malignant glioma	0.00693	0.0139	CcSEcCtD
Donepezil—Transient ischaemic attack—Temozolomide—malignant glioma	0.00693	0.0139	CcSEcCtD
Donepezil—HRH3—cerebellum—malignant glioma	0.00688	0.0304	CbGeAlD
Donepezil—ACHE—telencephalon—malignant glioma	0.0067	0.0296	CbGeAlD
Donepezil—Cerebral haemorrhage—Carmustine—malignant glioma	0.00654	0.0131	CcSEcCtD
Donepezil—Cerebral haemorrhage—Temozolomide—malignant glioma	0.00632	0.0126	CcSEcCtD
Donepezil—Transaminases increased—Carmustine—malignant glioma	0.00595	0.0119	CcSEcCtD
Donepezil—Haemorrhoids—Temozolomide—malignant glioma	0.00595	0.0119	CcSEcCtD
Donepezil—Deep vein thrombosis—Temozolomide—malignant glioma	0.00575	0.0115	CcSEcCtD
Donepezil—HRH3—brain—malignant glioma	0.00559	0.0247	CbGeAlD
Donepezil—Aphasia—Carmustine—malignant glioma	0.00558	0.0112	CcSEcCtD
Donepezil—Cyst—Carmustine—malignant glioma	0.00541	0.0108	CcSEcCtD
Donepezil—Aphasia—Temozolomide—malignant glioma	0.00539	0.0108	CcSEcCtD
Donepezil—Hypokinesia—Carmustine—malignant glioma	0.00536	0.0107	CcSEcCtD
Donepezil—HTR2A—endothelium—malignant glioma	0.00535	0.0237	CbGeAlD
Donepezil—Paranoia—Carmustine—malignant glioma	0.00531	0.0106	CcSEcCtD
Donepezil—ACHE—medulla oblongata—malignant glioma	0.00526	0.0233	CbGeAlD
Donepezil—HTR2A—blood vessel—malignant glioma	0.00494	0.0218	CbGeAlD
Donepezil—Apathy—Temozolomide—malignant glioma	0.0049	0.00979	CcSEcCtD
Donepezil—Flat affect—Temozolomide—malignant glioma	0.00485	0.0097	CcSEcCtD
Donepezil—ACHE—midbrain—malignant glioma	0.00481	0.0213	CbGeAlD
Donepezil—ACHE—spinal cord—malignant glioma	0.00469	0.0207	CbGeAlD
Donepezil—Herpes zoster—Temozolomide—malignant glioma	0.00464	0.00929	CcSEcCtD
Donepezil—Extrapyramidal disorder—Temozolomide—malignant glioma	0.00464	0.00929	CcSEcCtD
Donepezil—Abscess—Carmustine—malignant glioma	0.00457	0.00915	CcSEcCtD
Donepezil—SIGMAR1—telencephalon—malignant glioma	0.00449	0.0199	CbGeAlD
Donepezil—Otitis media—Temozolomide—malignant glioma	0.00449	0.00898	CcSEcCtD
Donepezil—Accidental injury—Carmustine—malignant glioma	0.00409	0.00818	CcSEcCtD
Donepezil—Leukocytosis—Carmustine—malignant glioma	0.00385	0.0077	CcSEcCtD
Donepezil—Hyperbilirubinaemia—Temozolomide—malignant glioma	0.00385	0.00769	CcSEcCtD
Donepezil—ACHE—cerebellum—malignant glioma	0.00372	0.0165	CbGeAlD
Donepezil—Gait disturbance—Carmustine—malignant glioma	0.00371	0.00742	CcSEcCtD
Donepezil—Hearing impaired—Temozolomide—malignant glioma	0.00367	0.00735	CcSEcCtD
Donepezil—Gait disturbance—Temozolomide—malignant glioma	0.00358	0.00717	CcSEcCtD
Donepezil—SIGMAR1—medulla oblongata—malignant glioma	0.00353	0.0156	CbGeAlD
Donepezil—Vaginal inflammation—Temozolomide—malignant glioma	0.0035	0.00699	CcSEcCtD
Donepezil—Phosphatase alkaline increased—Temozolomide—malignant glioma	0.0035	0.00699	CcSEcCtD
Donepezil—Urinary incontinence—Carmustine—malignant glioma	0.00349	0.00699	CcSEcCtD
Donepezil—Urinary incontinence—Temozolomide—malignant glioma	0.00338	0.00675	CcSEcCtD
Donepezil—Vaginal infection—Temozolomide—malignant glioma	0.0033	0.0066	CcSEcCtD
Donepezil—Dry eye—Temozolomide—malignant glioma	0.00323	0.00646	CcSEcCtD
Donepezil—SIGMAR1—midbrain—malignant glioma	0.00323	0.0143	CbGeAlD
Donepezil—Abnormal vision—Carmustine—malignant glioma	0.00316	0.00631	CcSEcCtD
Donepezil—SIGMAR1—spinal cord—malignant glioma	0.00315	0.0139	CbGeAlD
Donepezil—Sepsis—Carmustine—malignant glioma	0.00314	0.00628	CcSEcCtD
Donepezil—Abnormal vision—Temozolomide—malignant glioma	0.00305	0.0061	CcSEcCtD
Donepezil—ACHE—brain—malignant glioma	0.00302	0.0134	CbGeAlD
Donepezil—Diabetes mellitus—Carmustine—malignant glioma	0.00302	0.00604	CcSEcCtD
Donepezil—Ear pain—Temozolomide—malignant glioma	0.00298	0.00595	CcSEcCtD
Donepezil—HTR2A—embryo—malignant glioma	0.00294	0.013	CbGeAlD
Donepezil—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.00292	0.00584	CcSEcCtD
Donepezil—Gastroenteritis—Temozolomide—malignant glioma	0.00286	0.00573	CcSEcCtD
Donepezil—Injury—Carmustine—malignant glioma	0.00286	0.00572	CcSEcCtD
Donepezil—Hot flush—Temozolomide—malignant glioma	0.00271	0.00543	CcSEcCtD
Donepezil—HTR2A—brainstem—malignant glioma	0.0027	0.0119	CbGeAlD
Donepezil—Menopausal symptoms—Temozolomide—malignant glioma	0.00269	0.00538	CcSEcCtD
Donepezil—Thirst—Temozolomide—malignant glioma	0.00267	0.00533	CcSEcCtD
Donepezil—Hyponatraemia—Carmustine—malignant glioma	0.00264	0.00528	CcSEcCtD
Donepezil—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.00263	0.00525	CcSEcCtD
Donepezil—HTR2A—retina—malignant glioma	0.0026	0.0115	CbGeAlD
Donepezil—Face oedema—Carmustine—malignant glioma	0.00254	0.00507	CcSEcCtD
Donepezil—Affect lability—Temozolomide—malignant glioma	0.0025	0.005	CcSEcCtD
Donepezil—SIGMAR1—cerebellum—malignant glioma	0.0025	0.011	CbGeAlD
Donepezil—Ataxia—Carmustine—malignant glioma	0.00247	0.00494	CcSEcCtD
Donepezil—CYP2D6—brainstem—malignant glioma	0.00246	0.0109	CbGeAlD
Donepezil—Face oedema—Temozolomide—malignant glioma	0.00245	0.0049	CcSEcCtD
Donepezil—Liver function test abnormal—Carmustine—malignant glioma	0.00243	0.00485	CcSEcCtD
Donepezil—Mood swings—Temozolomide—malignant glioma	0.0024	0.00481	CcSEcCtD
Donepezil—HTR2A—telencephalon—malignant glioma	0.00239	0.0106	CbGeAlD
Donepezil—Hypokalaemia—Carmustine—malignant glioma	0.00239	0.00478	CcSEcCtD
Donepezil—Ataxia—Temozolomide—malignant glioma	0.00239	0.00477	CcSEcCtD
Donepezil—Dehydration—Temozolomide—malignant glioma	0.00236	0.00472	CcSEcCtD
Donepezil—Dry skin—Temozolomide—malignant glioma	0.00233	0.00465	CcSEcCtD
Donepezil—Muscular weakness—Carmustine—malignant glioma	0.00232	0.00463	CcSEcCtD
Donepezil—Hypokalaemia—Temozolomide—malignant glioma	0.00231	0.00462	CcSEcCtD
Donepezil—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.00229	0.00457	CcSEcCtD
Donepezil—Dysphagia—Carmustine—malignant glioma	0.00227	0.00454	CcSEcCtD
Donepezil—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.00224	0.00448	CcSEcCtD
Donepezil—Muscular weakness—Temozolomide—malignant glioma	0.00224	0.00448	CcSEcCtD
Donepezil—Abdominal distension—Temozolomide—malignant glioma	0.00221	0.00442	CcSEcCtD
Donepezil—Dysphagia—Temozolomide—malignant glioma	0.00219	0.00439	CcSEcCtD
Donepezil—CYP2D6—telencephalon—malignant glioma	0.00218	0.00964	CbGeAlD
Donepezil—Sweating increased—Temozolomide—malignant glioma	0.00214	0.00427	CcSEcCtD
Donepezil—Bronchitis—Temozolomide—malignant glioma	0.00211	0.00422	CcSEcCtD
Donepezil—Dysuria—Temozolomide—malignant glioma	0.00205	0.0041	CcSEcCtD
Donepezil—Hyperglycaemia—Carmustine—malignant glioma	0.00205	0.0041	CcSEcCtD
Donepezil—Pneumonia—Carmustine—malignant glioma	0.00204	0.00407	CcSEcCtD
Donepezil—SIGMAR1—brain—malignant glioma	0.00203	0.00896	CbGeAlD
Donepezil—Pollakiuria—Temozolomide—malignant glioma	0.00203	0.00405	CcSEcCtD
Donepezil—Depression—Carmustine—malignant glioma	0.00202	0.00404	CcSEcCtD
Donepezil—Weight increased—Temozolomide—malignant glioma	0.002	0.00399	CcSEcCtD
Donepezil—Renal failure—Carmustine—malignant glioma	0.00199	0.00398	CcSEcCtD
Donepezil—Weight decreased—Temozolomide—malignant glioma	0.00198	0.00397	CcSEcCtD
Donepezil—Hyperglycaemia—Temozolomide—malignant glioma	0.00198	0.00396	CcSEcCtD
Donepezil—Urinary tract infection—Carmustine—malignant glioma	0.00197	0.00394	CcSEcCtD
Donepezil—Pneumonia—Temozolomide—malignant glioma	0.00197	0.00394	CcSEcCtD
Donepezil—Infestation NOS—Temozolomide—malignant glioma	0.00196	0.00391	CcSEcCtD
Donepezil—Infestation—Temozolomide—malignant glioma	0.00196	0.00391	CcSEcCtD
Donepezil—Depression—Temozolomide—malignant glioma	0.00195	0.0039	CcSEcCtD
Donepezil—Urinary tract infection—Temozolomide—malignant glioma	0.0019	0.0038	CcSEcCtD
Donepezil—HTR2A—medulla oblongata—malignant glioma	0.00188	0.00832	CbGeAlD
Donepezil—Haemoglobin—Carmustine—malignant glioma	0.00183	0.00365	CcSEcCtD
Donepezil—Haemorrhage—Carmustine—malignant glioma	0.00182	0.00363	CcSEcCtD
Donepezil—Hypoaesthesia—Carmustine—malignant glioma	0.00181	0.00362	CcSEcCtD
Donepezil—Hallucination—Carmustine—malignant glioma	0.00181	0.00362	CcSEcCtD
Donepezil—Oedema peripheral—Carmustine—malignant glioma	0.00179	0.00358	CcSEcCtD
Donepezil—Haemoglobin—Temozolomide—malignant glioma	0.00177	0.00353	CcSEcCtD
Donepezil—Hepatitis—Temozolomide—malignant glioma	0.00176	0.00351	CcSEcCtD
Donepezil—Haemorrhage—Temozolomide—malignant glioma	0.00176	0.00351	CcSEcCtD
Donepezil—Visual impairment—Carmustine—malignant glioma	0.00175	0.0035	CcSEcCtD
Donepezil—Hallucination—Temozolomide—malignant glioma	0.00175	0.00349	CcSEcCtD
Donepezil—Hypoaesthesia—Temozolomide—malignant glioma	0.00175	0.00349	CcSEcCtD
Donepezil—Pharyngitis—Temozolomide—malignant glioma	0.00174	0.00349	CcSEcCtD
Donepezil—Urinary tract disorder—Temozolomide—malignant glioma	0.00173	0.00347	CcSEcCtD
Donepezil—Oedema peripheral—Temozolomide—malignant glioma	0.00173	0.00346	CcSEcCtD
Donepezil—Urethral disorder—Temozolomide—malignant glioma	0.00172	0.00344	CcSEcCtD
Donepezil—HTR2A—midbrain—malignant glioma	0.00172	0.0076	CbGeAlD
Donepezil—Visual impairment—Temozolomide—malignant glioma	0.00169	0.00338	CcSEcCtD
Donepezil—HTR2A—spinal cord—malignant glioma	0.00168	0.00742	CbGeAlD
Donepezil—Tinnitus—Temozolomide—malignant glioma	0.00164	0.00327	CcSEcCtD
Donepezil—Arrhythmia—Carmustine—malignant glioma	0.00162	0.00325	CcSEcCtD
Donepezil—Alopecia—Carmustine—malignant glioma	0.00161	0.00321	CcSEcCtD
Donepezil—Mental disorder—Carmustine—malignant glioma	0.00159	0.00318	CcSEcCtD
Donepezil—Malnutrition—Carmustine—malignant glioma	0.00158	0.00316	CcSEcCtD
Donepezil—Erythema—Carmustine—malignant glioma	0.00158	0.00316	CcSEcCtD
Donepezil—Chills—Temozolomide—malignant glioma	0.00158	0.00315	CcSEcCtD
Donepezil—Alopecia—Temozolomide—malignant glioma	0.00155	0.0031	CcSEcCtD
Donepezil—Mental disorder—Temozolomide—malignant glioma	0.00154	0.00308	CcSEcCtD
Donepezil—Back pain—Carmustine—malignant glioma	0.00153	0.00306	CcSEcCtD
Donepezil—Malnutrition—Temozolomide—malignant glioma	0.00153	0.00306	CcSEcCtD
Donepezil—Erythema—Temozolomide—malignant glioma	0.00153	0.00306	CcSEcCtD
Donepezil—Dysgeusia—Temozolomide—malignant glioma	0.0015	0.00299	CcSEcCtD
Donepezil—Vision blurred—Carmustine—malignant glioma	0.00149	0.00298	CcSEcCtD
Donepezil—Tremor—Carmustine—malignant glioma	0.00148	0.00296	CcSEcCtD
Donepezil—Back pain—Temozolomide—malignant glioma	0.00148	0.00296	CcSEcCtD
Donepezil—Anaemia—Carmustine—malignant glioma	0.00146	0.00292	CcSEcCtD
Donepezil—Agitation—Carmustine—malignant glioma	0.00145	0.00291	CcSEcCtD
Donepezil—Vision blurred—Temozolomide—malignant glioma	0.00144	0.00288	CcSEcCtD
Donepezil—Tremor—Temozolomide—malignant glioma	0.00143	0.00286	CcSEcCtD
Donepezil—Ill-defined disorder—Temozolomide—malignant glioma	0.00142	0.00284	CcSEcCtD
Donepezil—Anaemia—Temozolomide—malignant glioma	0.00141	0.00283	CcSEcCtD
Donepezil—Agitation—Temozolomide—malignant glioma	0.0014	0.00281	CcSEcCtD
Donepezil—Malaise—Temozolomide—malignant glioma	0.00138	0.00276	CcSEcCtD
Donepezil—Vertigo—Temozolomide—malignant glioma	0.00137	0.00275	CcSEcCtD
Donepezil—Convulsion—Carmustine—malignant glioma	0.00137	0.00274	CcSEcCtD
Donepezil—Hypertension—Carmustine—malignant glioma	0.00137	0.00273	CcSEcCtD
Donepezil—HTR2A—central nervous system—malignant glioma	0.00136	0.00602	CbGeAlD
Donepezil—Myalgia—Carmustine—malignant glioma	0.00135	0.00269	CcSEcCtD
Donepezil—Chest pain—Carmustine—malignant glioma	0.00135	0.00269	CcSEcCtD
Donepezil—Anxiety—Carmustine—malignant glioma	0.00134	0.00268	CcSEcCtD
Donepezil—Cough—Temozolomide—malignant glioma	0.00133	0.00267	CcSEcCtD
Donepezil—HTR2A—cerebellum—malignant glioma	0.00133	0.00588	CbGeAlD
Donepezil—Convulsion—Temozolomide—malignant glioma	0.00132	0.00265	CcSEcCtD
Donepezil—Hypertension—Temozolomide—malignant glioma	0.00132	0.00264	CcSEcCtD
Donepezil—Confusional state—Carmustine—malignant glioma	0.0013	0.0026	CcSEcCtD
Donepezil—Myalgia—Temozolomide—malignant glioma	0.0013	0.0026	CcSEcCtD
Donepezil—Arthralgia—Temozolomide—malignant glioma	0.0013	0.0026	CcSEcCtD
Donepezil—Anxiety—Temozolomide—malignant glioma	0.0013	0.00259	CcSEcCtD
Donepezil—Oedema—Carmustine—malignant glioma	0.00129	0.00258	CcSEcCtD
Donepezil—Discomfort—Temozolomide—malignant glioma	0.00129	0.00257	CcSEcCtD
Donepezil—Infection—Carmustine—malignant glioma	0.00128	0.00257	CcSEcCtD
Donepezil—Dry mouth—Temozolomide—malignant glioma	0.00127	0.00255	CcSEcCtD
Donepezil—Thrombocytopenia—Carmustine—malignant glioma	0.00126	0.00253	CcSEcCtD
Donepezil—CYP3A4—central nervous system—malignant glioma	0.00126	0.00557	CbGeAlD
Donepezil—Confusional state—Temozolomide—malignant glioma	0.00126	0.00252	CcSEcCtD
Donepezil—Oedema—Temozolomide—malignant glioma	0.00125	0.0025	CcSEcCtD
Donepezil—CYP2D6—central nervous system—malignant glioma	0.00124	0.00548	CbGeAlD
Donepezil—Infection—Temozolomide—malignant glioma	0.00124	0.00248	CcSEcCtD
Donepezil—Anorexia—Carmustine—malignant glioma	0.00123	0.00246	CcSEcCtD
Donepezil—Nervous system disorder—Temozolomide—malignant glioma	0.00122	0.00245	CcSEcCtD
Donepezil—Thrombocytopenia—Temozolomide—malignant glioma	0.00122	0.00244	CcSEcCtD
Donepezil—CYP2D6—cerebellum—malignant glioma	0.00121	0.00536	CbGeAlD
Donepezil—Hypotension—Carmustine—malignant glioma	0.00121	0.00241	CcSEcCtD
Donepezil—Hyperhidrosis—Temozolomide—malignant glioma	0.00121	0.00241	CcSEcCtD
Donepezil—Anorexia—Temozolomide—malignant glioma	0.00119	0.00238	CcSEcCtD
Donepezil—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00118	0.00235	CcSEcCtD
Donepezil—Insomnia—Carmustine—malignant glioma	0.00117	0.00234	CcSEcCtD
Donepezil—Paraesthesia—Carmustine—malignant glioma	0.00116	0.00232	CcSEcCtD
Donepezil—Dyspnoea—Carmustine—malignant glioma	0.00115	0.0023	CcSEcCtD
Donepezil—Somnolence—Carmustine—malignant glioma	0.00115	0.0023	CcSEcCtD
Donepezil—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00114	0.00227	CcSEcCtD
Donepezil—Insomnia—Temozolomide—malignant glioma	0.00113	0.00226	CcSEcCtD
Donepezil—Decreased appetite—Carmustine—malignant glioma	0.00112	0.00224	CcSEcCtD
Donepezil—Paraesthesia—Temozolomide—malignant glioma	0.00112	0.00224	CcSEcCtD
Donepezil—Gastrointestinal disorder—Carmustine—malignant glioma	0.00111	0.00223	CcSEcCtD
Donepezil—Dyspnoea—Temozolomide—malignant glioma	0.00111	0.00222	CcSEcCtD
Donepezil—Somnolence—Temozolomide—malignant glioma	0.00111	0.00222	CcSEcCtD
Donepezil—Constipation—Carmustine—malignant glioma	0.0011	0.00221	CcSEcCtD
Donepezil—Pain—Carmustine—malignant glioma	0.0011	0.00221	CcSEcCtD
Donepezil—Dyspepsia—Temozolomide—malignant glioma	0.0011	0.0022	CcSEcCtD
Donepezil—Decreased appetite—Temozolomide—malignant glioma	0.00108	0.00217	CcSEcCtD
Donepezil—HTR2A—brain—malignant glioma	0.00108	0.00478	CbGeAlD
Donepezil—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00108	0.00215	CcSEcCtD
Donepezil—Fatigue—Temozolomide—malignant glioma	0.00108	0.00215	CcSEcCtD
Donepezil—Constipation—Temozolomide—malignant glioma	0.00107	0.00213	CcSEcCtD
Donepezil—Pain—Temozolomide—malignant glioma	0.00107	0.00213	CcSEcCtD
Donepezil—Feeling abnormal—Carmustine—malignant glioma	0.00106	0.00213	CcSEcCtD
Donepezil—Gastrointestinal pain—Carmustine—malignant glioma	0.00106	0.00211	CcSEcCtD
Donepezil—Feeling abnormal—Temozolomide—malignant glioma	0.00103	0.00206	CcSEcCtD
Donepezil—Abdominal pain—Carmustine—malignant glioma	0.00102	0.00204	CcSEcCtD
Donepezil—Body temperature increased—Carmustine—malignant glioma	0.00102	0.00204	CcSEcCtD
Donepezil—Gastrointestinal pain—Temozolomide—malignant glioma	0.00102	0.00204	CcSEcCtD
Donepezil—Urticaria—Temozolomide—malignant glioma	0.000991	0.00198	CcSEcCtD
Donepezil—Abdominal pain—Temozolomide—malignant glioma	0.000986	0.00197	CcSEcCtD
Donepezil—Body temperature increased—Temozolomide—malignant glioma	0.000986	0.00197	CcSEcCtD
Donepezil—CYP2D6—brain—malignant glioma	0.000984	0.00435	CbGeAlD
Donepezil—Hypersensitivity—Carmustine—malignant glioma	0.000951	0.0019	CcSEcCtD
Donepezil—Asthenia—Carmustine—malignant glioma	0.000926	0.00185	CcSEcCtD
Donepezil—Hypersensitivity—Temozolomide—malignant glioma	0.000919	0.00184	CcSEcCtD
Donepezil—Asthenia—Temozolomide—malignant glioma	0.000895	0.00179	CcSEcCtD
Donepezil—Diarrhoea—Carmustine—malignant glioma	0.000883	0.00177	CcSEcCtD
Donepezil—Pruritus—Temozolomide—malignant glioma	0.000883	0.00177	CcSEcCtD
Donepezil—Dizziness—Carmustine—malignant glioma	0.000854	0.00171	CcSEcCtD
Donepezil—Diarrhoea—Temozolomide—malignant glioma	0.000854	0.00171	CcSEcCtD
Donepezil—Dizziness—Temozolomide—malignant glioma	0.000825	0.00165	CcSEcCtD
Donepezil—Vomiting—Carmustine—malignant glioma	0.000821	0.00164	CcSEcCtD
Donepezil—Rash—Carmustine—malignant glioma	0.000814	0.00163	CcSEcCtD
Donepezil—Dermatitis—Carmustine—malignant glioma	0.000813	0.00163	CcSEcCtD
Donepezil—Headache—Carmustine—malignant glioma	0.000809	0.00162	CcSEcCtD
Donepezil—Vomiting—Temozolomide—malignant glioma	0.000793	0.00159	CcSEcCtD
Donepezil—Rash—Temozolomide—malignant glioma	0.000787	0.00157	CcSEcCtD
Donepezil—Dermatitis—Temozolomide—malignant glioma	0.000786	0.00157	CcSEcCtD
Donepezil—Headache—Temozolomide—malignant glioma	0.000782	0.00156	CcSEcCtD
Donepezil—Nausea—Carmustine—malignant glioma	0.000767	0.00153	CcSEcCtD
Donepezil—Nausea—Temozolomide—malignant glioma	0.000741	0.00148	CcSEcCtD
Donepezil—HRH3—Signaling by GPCR—IL2—malignant glioma	0.000101	0.000575	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—DTX1—malignant glioma	0.000101	0.000575	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—TERT—malignant glioma	0.0001	0.000573	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	9.92e-05	0.000566	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—COX8A—malignant glioma	9.87e-05	0.000563	CbGpPWpGaD
Donepezil—ACHE—Metabolism of proteins—F2—malignant glioma	9.8e-05	0.00056	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—PDGFB—malignant glioma	9.79e-05	0.000559	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—COX8A—malignant glioma	9.78e-05	0.000559	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—FGFR1—malignant glioma	9.74e-05	0.000556	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—F2—malignant glioma	9.64e-05	0.00055	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—HIF1A—malignant glioma	9.59e-05	0.000548	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PTGS1—malignant glioma	9.58e-05	0.000547	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	9.54e-05	0.000545	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—CAV1—malignant glioma	9.28e-05	0.00053	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—BDKRB2—malignant glioma	9.27e-05	0.000529	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—CXCR3—malignant glioma	9.2e-05	0.000525	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—KDR—malignant glioma	9.17e-05	0.000524	CbGpPWpGaD
Donepezil—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—malignant glioma	8.92e-05	0.000509	CbGpPWpGaD
Donepezil—ACHE—Metabolism—BCHE—malignant glioma	8.91e-05	0.000508	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—F2—malignant glioma	8.83e-05	0.000504	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—FN1—malignant glioma	8.83e-05	0.000504	CbGpPWpGaD
Donepezil—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—malignant glioma	8.81e-05	0.000503	CbGpPWpGaD
Donepezil—ACHE—Metabolism—SLC5A5—malignant glioma	8.8e-05	0.000502	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	8.75e-05	0.000499	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—BAD—malignant glioma	8.72e-05	0.000498	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—NOTCH1—malignant glioma	8.64e-05	0.000493	CbGpPWpGaD
Donepezil—HTR2A—G alpha (q) signalling events—PIK3CA—malignant glioma	8.55e-05	0.000488	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—CD80—malignant glioma	8.46e-05	0.000483	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—APC—malignant glioma	8.45e-05	0.000482	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—PIK3CG—malignant glioma	8.45e-05	0.000482	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—KNG1—malignant glioma	8.43e-05	0.000481	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—BDKRB2—malignant glioma	8.41e-05	0.00048	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ASMT—malignant glioma	8.39e-05	0.000479	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—EGF—malignant glioma	8.35e-05	0.000477	CbGpPWpGaD
Donepezil—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—malignant glioma	8.32e-05	0.000475	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ASMT—malignant glioma	8.32e-05	0.000475	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	8.32e-05	0.000475	CbGpPWpGaD
Donepezil—ACHE—Metabolism of proteins—MMP2—malignant glioma	8.31e-05	0.000475	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—PTPN11—malignant glioma	8.3e-05	0.000474	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	8.24e-05	0.000471	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	8.13e-05	0.000464	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—SUFU—malignant glioma	8e-05	0.000456	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—BRAF—malignant glioma	7.94e-05	0.000453	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—HEY2—malignant glioma	7.9e-05	0.000451	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—BCAN—malignant glioma	7.89e-05	0.00045	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—BCAN—malignant glioma	7.82e-05	0.000447	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—AKT2—malignant glioma	7.73e-05	0.000441	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—GFAP—malignant glioma	7.71e-05	0.00044	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—EGFR—malignant glioma	7.7e-05	0.000439	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—KNG1—malignant glioma	7.66e-05	0.000437	CbGpPWpGaD
Donepezil—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—malignant glioma	7.64e-05	0.000436	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—SPHK1—malignant glioma	7.46e-05	0.000426	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—PIK3CD—malignant glioma	7.43e-05	0.000424	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—PIK3CA—malignant glioma	7.36e-05	0.00042	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CCR4—malignant glioma	7.31e-05	0.000417	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—HEY1—malignant glioma	7.31e-05	0.000417	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—KRAS—malignant glioma	7.27e-05	0.000415	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	7.19e-05	0.00041	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—FGF2—malignant glioma	7.11e-05	0.000406	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—HIST1H3B—malignant glioma	7.1e-05	0.000406	CbGpPWpGaD
Donepezil—ACHE—Metabolism—GSTP1—malignant glioma	7.09e-05	0.000405	CbGpPWpGaD
Donepezil—ACHE—Metabolism of proteins—CXCL8—malignant glioma	6.91e-05	0.000394	CbGpPWpGaD
Donepezil—ACHE—Metabolism—CAT—malignant glioma	6.89e-05	0.000394	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—CXCL8—malignant glioma	6.79e-05	0.000388	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—MMP3—malignant glioma	6.78e-05	0.000387	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—PIK3CA—malignant glioma	6.68e-05	0.000381	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—MDM2—malignant glioma	6.65e-05	0.00038	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—RAF1—malignant glioma	6.63e-05	0.000379	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—ERBB2—malignant glioma	6.56e-05	0.000375	CbGpPWpGaD
Donepezil—ACHE—Metabolism—NCOR1—malignant glioma	6.51e-05	0.000372	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—JAG2—malignant glioma	6.49e-05	0.00037	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—PIK3CB—malignant glioma	6.47e-05	0.00037	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—COX8A—malignant glioma	6.45e-05	0.000368	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—IDH2—malignant glioma	6.36e-05	0.000363	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—IDH2—malignant glioma	6.3e-05	0.00036	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—CXCL8—malignant glioma	6.22e-05	0.000355	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—AKT1—malignant glioma	6.01e-05	0.000343	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CYP2B6—malignant glioma	5.98e-05	0.000341	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—CASP3—malignant glioma	5.95e-05	0.00034	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—IL2—malignant glioma	5.95e-05	0.000339	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	5.95e-05	0.000339	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CYP2B6—malignant glioma	5.93e-05	0.000338	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—MMP9—malignant glioma	5.63e-05	0.000321	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—PTEN—malignant glioma	5.59e-05	0.000319	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—H3F3A—malignant glioma	5.49e-05	0.000313	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ASMT—malignant glioma	5.49e-05	0.000313	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—IDH1—malignant glioma	5.47e-05	0.000312	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—AKT1—malignant glioma	5.46e-05	0.000312	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—F2—malignant glioma	5.45e-05	0.000311	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CXCR3—malignant glioma	5.43e-05	0.00031	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—IDH1—malignant glioma	5.42e-05	0.00031	CbGpPWpGaD
Donepezil—ACHE—Metabolism—CAV1—malignant glioma	5.31e-05	0.000303	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—SPHK1—malignant glioma	5.29e-05	0.000302	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—YWHAE—malignant glioma	5.29e-05	0.000302	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—NTRK2—malignant glioma	5.29e-05	0.000302	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—FLT1—malignant glioma	5.26e-05	0.0003	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—SPHK1—malignant glioma	5.25e-05	0.0003	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—DUSP6—malignant glioma	5.24e-05	0.000299	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—PIK3CG—malignant glioma	5.21e-05	0.000298	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CYP2C18—malignant glioma	5.18e-05	0.000296	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—JAG1—malignant glioma	5.17e-05	0.000295	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—BCAN—malignant glioma	5.16e-05	0.000295	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—NOTCH3—malignant glioma	5.15e-05	0.000294	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CYP2C18—malignant glioma	5.14e-05	0.000293	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	5.07e-05	0.00029	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—FBXW7—malignant glioma	5.07e-05	0.000289	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—VEGFA—malignant glioma	5.05e-05	0.000288	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—STAT3—malignant glioma	5e-05	0.000286	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—BDKRB2—malignant glioma	4.97e-05	0.000284	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—F2—malignant glioma	4.95e-05	0.000282	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	4.85e-05	0.000277	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PIK3CG—malignant glioma	4.83e-05	0.000276	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—AKT2—malignant glioma	4.77e-05	0.000272	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—PIK3CG—malignant glioma	4.74e-05	0.00027	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PPARG—malignant glioma	4.67e-05	0.000266	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—PTPN11—malignant glioma	4.65e-05	0.000266	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—MYC—malignant glioma	4.65e-05	0.000265	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—NOTCH2—malignant glioma	4.62e-05	0.000264	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—PIK3CD—malignant glioma	4.58e-05	0.000262	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—EGFR—malignant glioma	4.55e-05	0.00026	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—KNG1—malignant glioma	4.52e-05	0.000258	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	4.41e-05	0.000252	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—AKT2—malignant glioma	4.33e-05	0.000247	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—NTRK1—malignant glioma	4.31e-05	0.000246	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—KRAS—malignant glioma	4.3e-05	0.000245	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	4.26e-05	0.000243	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PIK3CD—malignant glioma	4.25e-05	0.000243	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GSTT1—malignant glioma	4.19e-05	0.000239	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—PIK3CD—malignant glioma	4.16e-05	0.000238	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—IDH2—malignant glioma	4.16e-05	0.000237	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GSTT1—malignant glioma	4.16e-05	0.000237	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—MMP3—malignant glioma	4.01e-05	0.000229	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—PIK3CB—malignant glioma	4e-05	0.000228	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CDKN2B—malignant glioma	3.97e-05	0.000227	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—PIK3CA—malignant glioma	3.95e-05	0.000225	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PTGS1—malignant glioma	3.93e-05	0.000224	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CYP2B6—malignant glioma	3.91e-05	0.000223	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PTGS1—malignant glioma	3.9e-05	0.000222	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	3.88e-05	0.000222	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PTK2—malignant glioma	3.86e-05	0.00022	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—CXCL8—malignant glioma	3.84e-05	0.000219	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—TP53—malignant glioma	3.82e-05	0.000218	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—HES1—malignant glioma	3.79e-05	0.000216	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—NCOR1—malignant glioma	3.77e-05	0.000215	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—RAF1—malignant glioma	3.72e-05	0.000212	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PIK3CB—malignant glioma	3.7e-05	0.000212	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PTGS2—malignant glioma	3.67e-05	0.00021	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—IL2—malignant glioma	3.67e-05	0.000209	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—BCHE—malignant glioma	3.65e-05	0.000209	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—PIK3CB—malignant glioma	3.63e-05	0.000207	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—BCHE—malignant glioma	3.62e-05	0.000207	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—SLC5A5—malignant glioma	3.61e-05	0.000206	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PDGFRA—malignant glioma	3.61e-05	0.000206	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—SLC5A5—malignant glioma	3.58e-05	0.000204	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—IDH1—malignant glioma	3.58e-05	0.000204	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—SPP1—malignant glioma	3.5e-05	0.0002	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—CXCL8—malignant glioma	3.49e-05	0.000199	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—SPHK1—malignant glioma	3.46e-05	0.000198	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CYP2C18—malignant glioma	3.39e-05	0.000194	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	3.38e-05	0.000193	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	3.35e-05	0.000191	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—IL2—malignant glioma	3.33e-05	0.00019	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—TERT—malignant glioma	3.32e-05	0.00019	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PDGFB—malignant glioma	3.24e-05	0.000185	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—AKT1—malignant glioma	3.22e-05	0.000184	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—FGFR1—malignant glioma	3.22e-05	0.000184	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PTEN—malignant glioma	3.2e-05	0.000183	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—HIF1A—malignant glioma	3.17e-05	0.000181	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CAV1—malignant glioma	3.07e-05	0.000175	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—KDR—malignant glioma	3.04e-05	0.000173	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.92e-05	0.000167	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—F2—malignant glioma	2.92e-05	0.000167	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—FN1—malignant glioma	2.92e-05	0.000167	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GSTP1—malignant glioma	2.91e-05	0.000166	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—BAD—malignant glioma	2.89e-05	0.000165	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GSTP1—malignant glioma	2.88e-05	0.000164	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—NOTCH1—malignant glioma	2.86e-05	0.000163	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CAT—malignant glioma	2.83e-05	0.000161	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CAT—malignant glioma	2.8e-05	0.00016	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CD80—malignant glioma	2.8e-05	0.00016	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PIK3CG—malignant glioma	2.8e-05	0.00016	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—APC—malignant glioma	2.8e-05	0.00016	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—EGF—malignant glioma	2.76e-05	0.000158	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PTPN11—malignant glioma	2.75e-05	0.000157	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GSTT1—malignant glioma	2.74e-05	0.000157	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—NCOR1—malignant glioma	2.67e-05	0.000152	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—NCOR1—malignant glioma	2.65e-05	0.000151	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—BRAF—malignant glioma	2.63e-05	0.00015	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PTGS1—malignant glioma	2.57e-05	0.000147	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—AKT2—malignant glioma	2.56e-05	0.000146	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—EGFR—malignant glioma	2.55e-05	0.000145	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PIK3CD—malignant glioma	2.46e-05	0.00014	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—PIK3CA—malignant glioma	2.44e-05	0.000139	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—KRAS—malignant glioma	2.41e-05	0.000137	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—BCHE—malignant glioma	2.39e-05	0.000136	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—SLC5A5—malignant glioma	2.36e-05	0.000135	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—FGF2—malignant glioma	2.35e-05	0.000134	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PIK3CA—malignant glioma	2.26e-05	0.000129	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—PIK3CA—malignant glioma	2.21e-05	0.000126	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—MDM2—malignant glioma	2.2e-05	0.000126	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—RAF1—malignant glioma	2.2e-05	0.000125	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CAV1—malignant glioma	2.18e-05	0.000124	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—ERBB2—malignant glioma	2.17e-05	0.000124	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CAV1—malignant glioma	2.16e-05	0.000123	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PIK3CB—malignant glioma	2.14e-05	0.000122	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.06e-05	0.000118	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CXCL8—malignant glioma	2.06e-05	0.000118	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—AKT1—malignant glioma	1.99e-05	0.000114	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PIK3CG—malignant glioma	1.98e-05	0.000113	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CASP3—malignant glioma	1.97e-05	0.000113	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—IL2—malignant glioma	1.97e-05	0.000112	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PIK3CG—malignant glioma	1.97e-05	0.000112	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PPARG—malignant glioma	1.91e-05	0.000109	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GSTP1—malignant glioma	1.9e-05	0.000108	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PPARG—malignant glioma	1.9e-05	0.000108	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—MMP9—malignant glioma	1.86e-05	0.000106	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PTEN—malignant glioma	1.85e-05	0.000106	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CAT—malignant glioma	1.85e-05	0.000106	CbGpPWpGaD
Donepezil—ACHE—Metabolism—AKT1—malignant glioma	1.84e-05	0.000105	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—AKT1—malignant glioma	1.81e-05	0.000103	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—NCOR1—malignant glioma	1.75e-05	9.97e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PIK3CD—malignant glioma	1.74e-05	9.95e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PIK3CD—malignant glioma	1.73e-05	9.87e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—VEGFA—malignant glioma	1.67e-05	9.55e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—STAT3—malignant glioma	1.66e-05	9.46e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—MYC—malignant glioma	1.54e-05	8.79e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PIK3CB—malignant glioma	1.52e-05	8.68e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PIK3CB—malignant glioma	1.51e-05	8.6e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PTGS2—malignant glioma	1.51e-05	8.6e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—EGFR—malignant glioma	1.51e-05	8.59e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PTGS2—malignant glioma	1.49e-05	8.52e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CAV1—malignant glioma	1.42e-05	8.13e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—KRAS—malignant glioma	1.42e-05	8.12e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PTEN—malignant glioma	1.31e-05	7.5e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PIK3CA—malignant glioma	1.31e-05	7.46e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PTEN—malignant glioma	1.3e-05	7.43e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PIK3CG—malignant glioma	1.3e-05	7.4e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—TP53—malignant glioma	1.26e-05	7.22e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PPARG—malignant glioma	1.25e-05	7.14e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PIK3CD—malignant glioma	1.14e-05	6.51e-05	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—AKT1—malignant glioma	1.07e-05	6.09e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PIK3CB—malignant glioma	9.93e-06	5.67e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PTGS2—malignant glioma	9.84e-06	5.62e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PIK3CA—malignant glioma	9.26e-06	5.29e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PIK3CA—malignant glioma	9.18e-06	5.24e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PTEN—malignant glioma	8.58e-06	4.9e-05	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—AKT1—malignant glioma	7.57e-06	4.32e-05	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—AKT1—malignant glioma	7.5e-06	4.28e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PIK3CA—malignant glioma	6.06e-06	3.46e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—AKT1—malignant glioma	4.95e-06	2.82e-05	CbGpPWpGaD
